CHICAGO - An experimental drug that triggers the immune system, the latest example of a new approach developed by a Houston scientist, benefited advanced bladder cancer patients who hadn't responded to standard treatment, researchers reported Saturday.

To continue reading this story, you will need to be a digital subscriber to HoustonChronicle.com.